DAMORA THERAPEUTICS, INC.

DMRA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
S-3 Dec 16, 2025 S-3
8-K/A Dec 9, 2025 8-K/A
SCHEDULE 13G Dec 5, 2025
SCHEDULE 13G Dec 5, 2025
D Nov 21, 2025
3 Nov 17, 2025 3
3 Nov 17, 2025 3
SCHEDULE 13D Nov 17, 2025
3 Nov 17, 2025 3
SCHEDULE 13G Nov 13, 2025
8-K Nov 10, 2025 8-K
10-Q Nov 6, 2025 10-Q
SCHEDULE 13D/A Oct 9, 2025
SCHEDULE 13D/A Sep 25, 2025
10-Q Aug 5, 2025 10-Q
4 Jul 8, 2025 4
4 Jul 8, 2025 4
4 Jul 8, 2025 4
8-K Jun 20, 2025 8-K
4 Jun 20, 2025 4
4 Jun 20, 2025 4
4 Jun 20, 2025 4
4 Jun 20, 2025 4
4 Jun 20, 2025 4
4 Jun 20, 2025 4
← Newer Page 4 of 15 · 351 filings Older →